Latest News:
- Bluebird puts €1.58m price on gene therapy Zynteglo
- A milestone in the treatment of b-thalassaemia – The 1st gene therapy for Transfusion Dependent β-Thalassaemia wins approval in Europe
- TIF actively participates in the 72nd World Health Assembly Meetings in Geneva, Switzerland
- World Blood Donor Day – 14 June 2019
- TIF’s e-registry for patients with thalassaemia is ready for piloting
TIF
